Department of Pharmacology Archives
NOTCH1 role in heart development
Jul. 3, 2017—The identification of a genetic culprit for hypoplastic left heart syndrome could lead to new treatments for the condition.
Cytokine linked to blindness
Jun. 30, 2017—A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.
Barnett honored by AHA for minority student advocacy
Jun. 29, 2017—Joey Barnett, Ph.D., professor of Pharmacology at Vanderbilt and director of the Office of Medical Student Research, has received the American Heart Association’s (AHA) Louis B. Russell Jr. Memorial Award for his efforts as an advocate for the career advancement of minority students and trainees in cardiovascular science, and for increased representation of underserved communities among the AHA volunteer base.
Pharmacology top teacher
Jun. 15, 2017—Ronald Emeson, Ph.D., is a three-time winner of the Teacher of the Year Award presented by graduate students in the Department of Pharmacology
Vanderbilt, Ono Pharmaceutical extend drug discovery agreement
May. 25, 2017—Vanderbilt University Medical Center (VUMC), Vanderbilt University and Japan-based Ono Pharmaceutical Co. Ltd. have expanded a drug discovery agreement initiated in 2015 that will now run through 2019.
Discovery Lecturer Kandel tackles age-related memory loss
May. 11, 2017—Eric Kandel, M.D., who was awarded the Nobel Prize in 2000 for discovering molecular mechanisms of memory storage, told the crowd at last week’s Flexner Discovery Lecture that he has recently become interested in memory in the aging brain.
Barnett named co-chair of VUSM Admissions Committee
Apr. 27, 2017—Joey Barnett, Ph.D., has been named co-chair of the Vanderbilt University School of Medicine Admissions Committee, effective July 1.
Nobel laureate and memory expert Kandel set for next Discovery Lecture
Apr. 27, 2017—Nobel laureate Eric R. Kandel, M.D., renowned for his studies of learning and memory, will give the next Flexner Discovery Lecture on Thursday, May 4.
Graduate student’s research lauded by P.E.O. Sisterhood
Apr. 20, 2017—Nicole Perry, a graduate student in Pharmacology at Vanderbilt University School of Medicine, is one of 100 doctoral students in the United States and Canada selected to receive a $15,000 P.E.O. Scholar Award this year from the P.E.O. Sisterhood, a philanthropic educational organization based in Des Moines, Iowa.
Emerging Scholar
Mar. 23, 2017—Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week.
Melanoma study finds new way to enhance targeted therapies
Mar. 9, 2017—With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.
Lindsley’s drug discovery efforts land ASPET Award
Jan. 12, 2017—Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
